Jing Xie

Jing Xie

Auto-generated profile, based on publicly available information

Jing Xie

Deanery of Biomedical Sciences, Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Neuroscience Bulletin
Verified
Journal Article
Open access
PDF file
JSJianwei Shi
Jianwei Shi
JXJing Xie
Jing Xie
ZLZesheng Li
Zesheng Li
XHXiaosong He
Xiaosong He
PWPenghu Wei
Penghu Wei
GZGuoguang Zhao
Guoguang Zhao
Epilepsy affects over 50 million people worldwide. Drug-resistant epilepsy (DRE) accounts for up to a third of these cases, and neuro-inflammation is thought to play a role in such cases. Despite being a long-debated issue in the field of DRE, the mechanisms underlying neuroinflammation have yet to be fully elucidated. The pro-inflammatory microenvironment within the brain tissue of people with DRE has been probed using single-cell multimodal transcriptomics. Evidence suggests that inflammatory cells and pro-inflammatory cytokines in the nervous system can lead to extensive biochemical changes, such as connexin hemichannel excitability and disruption of neurotransmitter homeostasis. The presence of inflammation may give rise to neuronal network abnormalities that suppress endogenous antiepileptic systems. We focus on the role of neuroinflammation and brain network anomalies in DRE from multiple perspectives to identify critical points for clinical application. We hope to provide an insightful overview to advance the quest for better DRE treatments.

9 December 2021 in Nephron
Verified
Journal Article
Open access
PDF file
ETEkamol Tantisattamo
Ekamol Tantisattamo
URUttam G. Reddy
Uttam G. Reddy
HIHirohito Ichii
Hirohito Ichii
AFAntoney J. Ferrey
Antoney J. Ferrey
DDDonald C. Dafoe
Donald C. Dafoe
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
Living donor kidney transplantation is an effective strategy to mitigate the challenges of solid organ shortage. However, being a living kidney donor is not without risk, as donors may encounter short- and long-term complications including the risk of developing chronic kidney disease, end-stage kidney disease, hypertension, and possible pregnancy-related complications. Although the evaluation of potential living donors is a thorough and meticulous process with the intention of decreasing the chance of complications, particularly in donors who have lifetime risk projection, risk factors for kidney disease including genetic predispositions may be missed because they are not routinely investigated. This type of testing may not be offered to patients due to variability and decreased penetrance of symptoms and lack of availability of appropriate genetic testing and genetic specialists. We report a case of a middle-aged woman with a history of gestational diabetes and preeclampsia who underwent an uneventful living kidney donation. She developed postdonation nonnephrotic range proteinuria and microscopic hematuria. Given the risk of biopsy with a solitary kidney, genetic testing was performed and revealed autosomal dominant Alport syndrome. Our case underscores the utility of genetic testing. Hopefully, future research will examine the incorporation of predonation genetic testing into living kidney donor evaluation.

15 November 2012
Verified
Book Chapter
Closed access
PDF file
LMLudwine Messiaen
Ludwine Messiaen
JXJing Xie
Jing Xie

23 April 2024 in Journal of Functional Foods
Verified
Journal Article
Open access
YCYacun Chen
Yacun Chen
JXJing Xie
Jing Xie
MWMeiling Wu
Meiling Wu
SYSulan Yu
Sulan Yu
JSJiangang Shen
Jiangang Shen
XLXiang Lin
Xiang Lin